{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:01:37Z","timestamp":1791302497359,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.clbc.2017.07.013","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T02:46:34Z","timestamp":1500518794000},"page":"e393-e399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"title":["Alarming Burden of Triple-Negative Breast Cancer in India"],"prefix":"10.1016","volume":"18","author":[{"given":"Krishan K.","family":"Thakur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devivasha","family":"Bordoloi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaikumar B.","family":"Kunnumakkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2017.07.013_bib1","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1007\/s13277-014-2052-4","article-title":"Association of promoter methylation of ERalpha and ERbeta with sporadic breast cancer\u2014a study from North India","volume":"35","author":"Chattopadhyay","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.clbc.2017.07.013_bib2","first-page":"686","article-title":"A\u00a0clinical and pathological study of triple negative breast carcinoma: experience of a tertiary care centre in eastern India","volume":"110","author":"Sen","year":"2012","journal-title":"J\u00a0Indian Med Assoc"},{"key":"10.1016\/j.clbc.2017.07.013_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4103\/0019-509X.123616","article-title":"Five year retrospective survival analysis of triple negative breast cancer in North-West India","volume":"50","author":"Sharma","year":"2013","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.clbc.2017.07.013_bib4","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2017.07.013_bib5","first-page":"239","article-title":"Triple negative breast cancer: an Indian perspective","volume":"7","author":"Akhtar","year":"2015","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.clbc.2017.07.013_bib6","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1007\/s00268-007-9454-z","article-title":"Breast cancer issues in developing countries: an overview of the Breast Health Global Initiative","volume":"32","author":"Anderson","year":"2008","journal-title":"World J Surg"},{"issue":"suppl 4","key":"10.1016\/j.clbc.2017.07.013_bib7","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/bcr2736","article-title":"The globalisation of breast cancer","volume":"12","author":"Boyle","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2017.07.013_bib8","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.7314\/APJCP.2014.15.6.2505","article-title":"Hypofractionated radiotherapy for breast cancers\u2014preliminary results from a tertiary care center in eastern India","volume":"15","author":"Nandi","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"issue":"suppl 6","key":"10.1016\/j.clbc.2017.07.013_bib9","doi-asserted-by":"crossref","first-page":"vi7","DOI":"10.1093\/annonc\/mds187","article-title":"Triple-negative breast cancer: epidemiological considerations and recommendations","volume":"23","author":"Boyle","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2017.07.013_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00404-015-3859-y","article-title":"An overview of triple-negative breast cancer","volume":"293","author":"Kumar","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.clbc.2017.07.013_bib11","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.7314\/APJCP.2014.15.11.4507","article-title":"Triple negative breast cancer in people of North East India: critical insights gained at a regional cancer centre","volume":"15","author":"Sharma","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clbc.2017.07.013_bib12","first-page":"E359","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2017.07.013_bib13","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.7314\/APJCP.2015.16.12.4959","article-title":"Immunohistochemical profile of breast cancer patients at a tertiary care hospital in New Delhi, India","volume":"16","author":"Doval","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clbc.2017.07.013_bib14","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.ejca.2012.04.019","article-title":"Tumor characteristics and recurrence patterns in triple negative breast cancer: a comparison between younger (<65) and elderly (>\/=65) patients","volume":"48","author":"Konigsberg","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2017.07.013_bib15","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMoa1510764","article-title":"Prospective validation of a 21-gene expression assay in breast cancer","volume":"373","author":"Sparano","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2017.07.013_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3816\/CBC.2009.n.005","article-title":"Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design","volume":"9","author":"Kassam","year":"2009","journal-title":"Clin Breast Cancer"},{"issue":"suppl 2","key":"10.1016\/j.clbc.2017.07.013_bib17","first-page":"001","article-title":"Triple negative breast cancer\u2014an overview","volume":"2013","author":"Aysola","year":"2013","journal-title":"Hereditary Genet"},{"key":"10.1016\/j.clbc.2017.07.013_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/modpathol.2010.200","article-title":"Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists","volume":"24","author":"Badve","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clbc.2017.07.013_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/0971-5851.116185","article-title":"Epidemiological and clinical profile of triple negative breast cancer at a cancer hospital in North India","volume":"34","author":"Suresh","year":"2013","journal-title":"Indian J Med Paediatr Oncol"},{"key":"10.1016\/j.clbc.2017.07.013_bib20","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1111\/bph.13211","article-title":"Therapeutic targets of triple-negative breast cancer: a review","volume":"172","author":"Jamdade","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clbc.2017.07.013_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12609-014-0144-1","article-title":"Advances in preventive therapy for estrogen-receptor-negative breast cancer","volume":"6","author":"Litzenburger","year":"2014","journal-title":"Curr Breast Cancer Rep"},{"key":"10.1016\/j.clbc.2017.07.013_bib22","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.7863\/jum.2012.31.10.1531","article-title":"Sonographic features of triple-negative and non-triple-negative breast cancer","volume":"31","author":"Wojcinski","year":"2012","journal-title":"J\u00a0Ultrasound Med"},{"key":"10.1016\/j.clbc.2017.07.013_bib23","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1158\/1078-0432.CCR-15-1555","article-title":"Comprehensive transcriptome profiling reveals multigene signatures in triple-negative breast cancer: a prospective observational study and validation","volume":"22","author":"Liu","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2017.07.013_bib24","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/PAS.0b013e3181e02f45","article-title":"Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers","volume":"34","author":"Thike","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clbc.2017.07.013_bib25","first-page":"337","article-title":"Distinct breast cancer subtypes in women with early-onset disease across races","volume":"4","author":"Singh","year":"2014","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.clbc.2017.07.013_bib26","doi-asserted-by":"crossref","first-page":"e625","DOI":"10.1016\/S1470-2045(14)70364-X","article-title":"Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry","volume":"15","author":"Brewster","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2017.07.013_bib27","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/cncr.22836","article-title":"Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database","volume":"110","author":"Morris","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2017.07.013_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lfs.2015.03.016","article-title":"Epigenetic regulation of protein tyrosine phosphatase PTPN12 in triple-negative breast cancer","volume":"130","author":"Thummuri","year":"2015","journal-title":"Life Sci"},{"key":"10.1016\/j.clbc.2017.07.013_bib29","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2017.07.013_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4174\/astr.2016.90.1.1","article-title":"Biologic subtype is a more important prognostic factor than nodal involvement in patients with stages I and II breast carcinoma","volume":"90","author":"Kim","year":"2016","journal-title":"Ann Surg Treat Res"},{"key":"10.1016\/j.clbc.2017.07.013_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2174\/092986713804999321","article-title":"Targeted approaches to triple-negative breast cancer: current practice and future directions","volume":"20","author":"Brunello","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.clbc.2017.07.013_bib32","first-page":"106","article-title":"Current approaches in treatment of triple-negative breast cancer","volume":"12","author":"Wahba","year":"2015","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.clbc.2017.07.013_bib33","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clbc.2017.07.013_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/BD-150398","article-title":"Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study","volume":"35","author":"Cherbal","year":"2015","journal-title":"Breast Dis"},{"key":"10.1016\/j.clbc.2017.07.013_bib35","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.7314\/APJCP.2013.14.10.6013","article-title":"Clinicopathologic and demographic evaluation of triple- negative breast cancer patients among a Turkish patient population: a single center experience","volume":"14","author":"Somali","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clbc.2017.07.013_bib36","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ejca.2011.06.028","article-title":"Management and treatment of triple-negative breast cancer patients from the NEMESI study: an Italian experience","volume":"48","author":"Adamo","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2017.07.013_bib37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/bjc.2012.270","article-title":"Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer","volume":"107","author":"Kwast","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2017.07.013_bib38","doi-asserted-by":"crossref","first-page":"e40543","DOI":"10.1371\/journal.pone.0040543","article-title":"Breast feeding, parity and breast cancer subtypes in a Spanish cohort","volume":"7","author":"Redondo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2017.07.013_bib39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10549-014-3167-4","article-title":"Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers","volume":"148","author":"Zugazagoitia","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2017.07.013_bib40","first-page":"377","article-title":"TNBC vs non-TNBC: a retrospective review of differences in mean age, family history, smoking history, and stage at diagnosis","volume":"12","author":"Tariq","year":"2014","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.clbc.2017.07.013_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3121\/cmr.2008.825","article-title":"Breast cancer subtypes based on ER\/PR and Her2 expression: comparison of clinicopathologic features and survival","volume":"7","author":"Onitilo","year":"2009","journal-title":"Clin Med Res"},{"key":"10.1016\/j.clbc.2017.07.013_bib42","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.22618","article-title":"Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry","volume":"109","author":"Bauer","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2017.07.013_bib43","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/bcr2242","article-title":"Triple-negative breast cancers are increased in black women regardless of age or body mass index","volume":"11","author":"Stead","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2017.07.013_bib44","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1158\/1055-9965.EPI-08-0544","article-title":"Triple-negative breast cancer and obesity in a rural Appalachian population","volume":"17","author":"Vona-Davis","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clbc.2017.07.013_bib45","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ejca.2012.09.012","article-title":"Differences in breast cancer hormone receptor status in ethnic groups: a London population","volume":"49","author":"Jack","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2017.07.013_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.rpor.2013.08.007","article-title":"Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: a comparative\/perspective analysis","volume":"19","author":"Fayaz","year":"2013","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.clbc.2017.07.013_bib47","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.7314\/APJCP.2012.13.5.2109","article-title":"Triple negative status is a poor prognostic indicator in Chinese women with breast cancer: a ten year review","volume":"13","author":"Ma","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clbc.2017.07.013_bib48","first-page":"428","article-title":"Prognostic effect analysis of molecular subtype on young breast cancer patients","volume":"27","author":"Chen","year":"2015","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.clbc.2017.07.013_bib49","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.7314\/APJCP.2013.14.6.3779","article-title":"Clinicopathological and prognostic characteristics of triple-negative breast cancer (TNBC) in Chinese patients: a retrospective study","volume":"14","author":"Li","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clbc.2017.07.013_bib50","first-page":"1065","article-title":"Clinicopathological features and prognosis of triple-negative breast cancer: a comparison between younger (<60) and elderly (>\/=60) patients","volume":"25","author":"Qiu","year":"2016","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.clbc.2017.07.013_bib51","first-page":"836","article-title":"Clinicopathological characteristics of basal type breast cancer in triple-negative breast cancer","volume":"3","author":"Kutomi","year":"2012","journal-title":"J\u00a0Cancer Ther"},{"key":"10.1016\/j.clbc.2017.07.013_bib52","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.7314\/APJCP.2014.15.15.6109","article-title":"Clinicopathological features of Indonesian breast cancers with different molecular subtypes","volume":"15","author":"Widodo","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clbc.2017.07.013_bib53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1746-1596-9-43","article-title":"Clinicopathologic features of triple negative breast cancers: an experience from Pakistan","volume":"9","author":"Hashmi","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.clbc.2017.07.013_bib54","doi-asserted-by":"crossref","first-page":"10577","DOI":"10.7314\/APJCP.2014.15.24.10577","article-title":"Clinicopathological characteristics of triple negative breast cancer at a tertiary care hospital in India","volume":"15","author":"Dogra","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clbc.2017.07.013_bib55","first-page":"12","article-title":"A\u00a0clinicopathologic study of triple negative breast cancer","volume":"42","author":"Gaopande","year":"2015","journal-title":"J\u00a0Sci Soc"},{"key":"10.1016\/j.clbc.2017.07.013_bib56","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0140-6736(12)60415-2","article-title":"India faces growing breast cancer epidemic","volume":"379","author":"Shetty","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2017.07.013_bib57","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/1119-3077.153248","article-title":"Clinicopathological comparison of triple negative breast cancers with non-triple negative breast cancers in a hospital in North India","volume":"18","author":"Nabi","year":"2015","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.clbc.2017.07.013_bib58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/2278-330X.136804","article-title":"A\u00a0retrospective study of clinico-pathological spectrum of carcinoma breast in a West Delhi, India","volume":"3","author":"Nigam","year":"2014","journal-title":"South Asian J Cancer"},{"key":"10.1016\/j.clbc.2017.07.013_bib59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/0019-509X.138275","article-title":"Triple-negative breast cancer: an institutional analysis","volume":"51","author":"Gogia","year":"2014","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.clbc.2017.07.013_bib60","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4103\/2141-9248.144917","article-title":"A\u00a0study of triple negative breast cancer at a tertiary cancer care center in southern India","volume":"4","author":"Lakshmaiah","year":"2014","journal-title":"Ann Med Health Sci Res"},{"key":"10.1016\/j.clbc.2017.07.013_bib61","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4103\/2278-0513.157940","article-title":"Hormone receptor expression in breast carcinoma at our hospital: an experience","volume":"4","author":"Geethamala","year":"2015","journal-title":"Clin Cancer Investig J"},{"key":"10.1016\/j.clbc.2017.07.013_bib62","first-page":"625","article-title":"Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India","volume":"12","author":"Ambroise","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clbc.2017.07.013_bib63","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0973-1482.131348","article-title":"Evaluation of ER, PR and HER-2 receptor expression in breast cancer patients presenting to a semi urban cancer centre in Western India","volume":"10","author":"Singh","year":"2014","journal-title":"J\u00a0Cancer Res Ther"},{"key":"10.1016\/j.clbc.2017.07.013_bib64","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4103\/0019-509X.92245","article-title":"Estrogen, progesterone and HER2 receptor expression in breast tumors of patients, and their usage of HER2-targeted therapy, in a tertiary care centre in India","volume":"48","author":"Ghosh","year":"2011","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.clbc.2017.07.013_bib65","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.7314\/APJCP.2013.14.4.2231","article-title":"Her-2\/neu status: a neglected marker of prognostication and management of breast cancer patients in India","volume":"14","author":"Zubeda","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clbc.2017.07.013_bib66","first-page":"141864","article-title":"Correlation of CK5 and EGFR with clinicopathological profile of triple-negative breast cancer","volume":"2014","author":"Sood","year":"2014","journal-title":"Patholog Res Int"},{"key":"10.1016\/j.clbc.2017.07.013_bib67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bionut.2013.03.001","article-title":"Breast cancer status in India: an overview","volume":"3","author":"Kumar","year":"2013","journal-title":"Biomed Prev Nutr"},{"key":"10.1016\/j.clbc.2017.07.013_bib68","first-page":"359","article-title":"Epidemiological risk factors associated with inflammatory breast cancer subtypes","volume":"27","author":"Atkinson","year":"2016","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clbc.2017.07.013_bib69","first-page":"13405","article-title":"Overexpression of the fat mass and obesity associated gene (FTO) in breast cancer and its clinical implications","volume":"8","author":"Tan","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.clbc.2017.07.013_bib70","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1158\/1055-9965.EPI-10-0974","article-title":"Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer","volume":"20","author":"Phipps","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clbc.2017.07.013_bib71","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1158\/1055-9965.EPI-15-1068","article-title":"Family history of cancer in relation to breast cancer subtypes in African American women","volume":"25","author":"Bethea","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clbc.2017.07.013_bib72","first-page":"259","article-title":"Alcohol intake and invasive breast cancer risk by molecular subtype and race in the Carolina Breast Cancer Study","volume":"27","author":"Williams","year":"2016","journal-title":"Cancer Causes Control"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682091730160X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682091730160X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:17:04Z","timestamp":1761513424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152682091730160X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S152682091730160X"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2017.07.013","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alarming Burden of Triple-Negative Breast Cancer in India","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2017.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}